Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Strategy

Set Alert for Strategy

Glenmark’s Lonhala Version Hits ‘Intriguing’ Indian Nebulizer Market

Glenmark’s nebulized, long-acting muscarinic antagonist for COPD has hit the Indian market. Delivered via a novel mesh nebulizer, it is seen as likely catering to a relatively small patient group.
Commercial Strategy

India Corporate Governance Practices – Will Pharma Walk The Gandhian Path?

As Sun Pharma firefights allegations of corporate governance lapses, Scrip speaks to multiple experts on how they view the governance landscape across Pharma Inc in India and also some key sticking points.
India Commercial

Sun Claims It Played By Rulebook As Corporate Governance Allegations Smoulder

Sun Pharma, which has been hit by allegations of grave lapses in corporate governance practices, has given its side of the story, essentially emphasizing that it has done no wrong. The company, however, signaled that it is open to reviewing certain operational arrangements should that improve investor confidence.
Commercial Strategy

Big Changes At Bayer With Animal Health Exit And 12,000 Jobs Cut

The German company is making some dramatic changes to its structure and in terms of pharma R&D, the focus will be very much on external alliances.

Strategy M & A

Sun To Trim US Manufacturing, Over 90 Jobs At Stake

Sun Pharma is consolidating its production activities in the US transferring operations out of its Cranbury site to the one in New Brunswick. Close to 100 jobs are expected to be affected.

Commercial Strategy

Pharma CEO Pay Up In India, Ratio Versus Employee Earnings Glaring

Pharma CEOs in India took home higher remuneration in 2017-18, with experts suggesting that the upward trend isn’t entirely unexpected. The huge CEO-to-employee pay ratios – over 600 in one case – isn’t a healthy trend, though.
Commercial Strategy

Eisai Seeks To Block Dr Reddy’s Over Belviq Plans In India

Eisai has moved court against Dr Reddy’s for alleged infringement of its patent on Belviq in India. The case is expected to put the spotlight back on prickly IPR issues, including working of patents.

Intellectual Property Legal Issues

Neuroscience Is The Next Oncology: Why Biogen Is Doubling Down

While other large biopharma companies are withdrawing from CNS research, Biogen is rare in not only staying in, but doubling down. Executives at the company’s 40th anniversary event in Switzerland explained why.

Leadership Strategy

RedHill Unveils Plans For Pivotal Phase III Study For Crohn’s Therapy

RedHill Biopharma’s study results for its novel antibiotic approach to Crohn’s disease has left the company with some unanswered questions, despite hitting its endpoints in a recent Phase III study. Its COO, Gilead Raday, talks to Scrip about the next steps for the study.

Gastrointestinal Research and Development Strategies
See All
Advertisement
UsernamePublicRestriction

Register